-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It is well known that in patients with cystic fibrosis (CF), mutations in the transmembrane conductance regulator of CFTR (CFtr) can significantly reduce the flow of chloride ions in the cells
It is well known that in patients with cystic fibrosis (CF), mutations in the transmembrane conductance regulator of CFTR (CFtr) can significantly reduce the flow of chloride ions in the cells
A total of 75 CF patients were included in this study: 25 were diagnosed with liver cirrhosis (11 women, 14 men, aged 9 to 33 years), and 25 had other non-cirrhotic liver diseases (12 women, 13 men) , 16 to 44 years old) and 25 without liver disease (12 females, 13 males, 17 to 36 years old)
The results of the study showed that, except for Glycyrrhiza deoxycholic acid (GDCA), bile acid levels in CF patients were higher than those in healthy controls
This study confirms that the specific bile acid profile in CF patients can be used to identify liver diseases
This study confirms that the specific bile acid profile in CF patients can be used to identify liver diseases
Sławomira Drzymała-Czy.
Serum bile acids in cystic fibrosis patients – glycodeoxycholic acid as a potential marker of liver disease.
Leave a message here